Showing results (71-80 of 86) with videos related to
Sort By:
Pageof 9
Elife|October 19, 2013
A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosisVirginie Olive, Erich Sabio, Margaux J Bennett, et al.Journal of Extracellular Vesicles|September 1, 2015
Biogenesis, delivery, and function of extracellular RNAJames G Patton, Jeffrey L Franklin, Alissa M Weaver, et al.Nature Medicine|November 8, 2016
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expressionDai Horiuchi, Roman Camarda, Alicia Y Zhou, et al.Cancer Discovery|December 16, 2014
Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction mapMaria M Martins, Alicia Y Zhou, Alexandra Corella, et al.Nature Microbiology|September 22, 2022
Host and gut bacteria share metabolic pathways for anti-cancer drug metabolismPeter Spanogiannopoulos, Than S Kyaw, Ben G H Guthrie, et al.Nature Medicine|September 28, 2010
miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastomaAlexander Swarbrick, Susan L Woods, Alexander Shaw, et al.Journal for Immunotherapy of Cancer|April 11, 2024
Respiratory complex I regulates dendritic cell maturation in explant model of human tumor immune microenvironmentRita Turpin, Ruixian Liu, Pauliina M Munne, et al.Nature Medicine|November 28, 2018
Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancerKhyati N Shah, Roma Bhatt, Julia Rotow, et al.Nature Communications|June 27, 2022
Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancerJoyce V Lee, Filomena Housley, Christina Yau, et al.Gastroenterology|August 31, 2018
microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress HepatocarcinogenesisSanchari Roy, Guido J Hooiveld, Marco Seehawer, et al.Pageof 9